Evaluation of Single-Dose Intravenous Infusions of Ferumoxytol for Iron Deficiency
A retrospective analysis suggests that for patients with iron deficiency, intravenous ferumoxytol may be safe and effective when used on a single-dose basis.
Hematologic Disorders
FDA: More Data on Remestemcel-L for Graft-vs-Host Disease Needed
In the CRL, the FDA recommended that the Company conduct at least 1 additional randomized, clinical study.
Outcomes of Systemic Lupus Erythematosus in Immune-Mediated Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (TTP) related to systemic lupus erythematosus may not cause worse outcomes compared with primary immune-mediated TTP.
Level of Health Literacy Among Patients With Thrombotic Thrombocytopenic Purpura
A team of investigators evaluated knowledge gaps among patients with TTP in remission and found a range of levels of understanding of the condition.
Thrombotic Thrombocytopenic Purpura: Expert Recommendations, Good Practice Statements for Critical Care
TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
Quercetin May Induce Autophagy in Myelodysplastic Bone Marrow, Mouse Model Suggests
A study with murine models suggests that quercetin may induce autophagy in myelodysplastic bone marrow among patients with myelodysplastic syndrome.
Haegarda Approved for Pediatric Hereditary Angioedema
The expanded approval was based on data from the pivotal phase 3 COMPACT study and the COMPACT open-label extension study.
FDA-Approved Biosimilars
A comparative list of biosimilars approved by the FDA including their reference products, dosage forms and indications.
FDA Approves Nucala for Hypereosinophilic Syndrome
The FDA has approved Nucala (mepolizumab; GlaxoSmithKline) for the treatment of hypereosinophilic syndrome (HES) for 6 months or longer without another identifiable non-blood related cause of the disease in patients aged 12 years and older.
-
Loading...
-
Loading...
